A new article from Purdue says making smart input decisions is about much more than price. Here are 12 factors to consider.

A modelling study shows the six-monthly anti-HIV jab, lenacapavir, could end Aids in SA by 2032 — but only if between two and four million HIV-negative people in the country would need to use the jab ...